Position in OGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$227,431
+$126,818 QoQ
Shares Held
16,797
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#227
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. OGN ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
|
28,162 | $4,413,548 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,431 | 16,797 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $100,613 | 16,797 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $123,301 | 17,197 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $210,363 | 19,697 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $205,002 | 21,178 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $317,275 | 21,308 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $322,196 | 21,595 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $570,054 | 29,799 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $506,197 | 24,454 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $378,199 | 20,117 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $328,977 | 22,814 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $433,669 | 24,981 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $558,560 | 26,841 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,946,772 | 167,805 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,047,647 | 180,725 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,327,187 | 612,273 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $58,341,935 | 1,728,650 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $60,721,331 | 1,738,372 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $53,228,729 | 1,748,070 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $57,498,673 | 1,753,543 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $53,224,856 | 1,758,918 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||